These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 17825714)

  • 1. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.
    Kempf T; Björklund E; Olofsson S; Lindahl B; Allhoff T; Peter T; Tongers J; Wollert KC; Wallentin L
    Eur Heart J; 2007 Dec; 28(23):2858-65. PubMed ID: 17977844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
    Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.
    Nickel N; Kempf T; Tapken H; Tongers J; Laenger F; Lehmann U; Golpon H; Olsson K; Wilkins MR; Gibbs JS; Hoeper MM; Wollert KC
    Am J Respir Crit Care Med; 2008 Sep; 178(5):534-41. PubMed ID: 18565955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-differentiation factor-15 in heart failure.
    Kempf T; Wollert KC
    Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.
    Lankeit M; Kempf T; Dellas C; Cuny M; Tapken H; Peter T; Olschewski M; Konstantinides S; Wollert KC
    Am J Respir Crit Care Med; 2008 May; 177(9):1018-25. PubMed ID: 18263797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
    Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
    Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
    Ceconi C; Ferrari R; Bachetti T; Opasich C; Volterrani M; Colombo B; Parrinello G; Corti A
    Eur Heart J; 2002 Jun; 23(12):967-74. PubMed ID: 12069452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure.
    Andreassen M; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Kristensen LØ; Faber J
    Growth Horm IGF Res; 2009 Dec; 19(6):486-90. PubMed ID: 19398211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.